![](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2024/07/11-shutterstock_1024526428.jpg)
Jaguar Gene’s JAG201 therapy trial for autism receives FDA approval
Jaguar Gene Therapy has received clearance from the US Food and Drug Administration (FDA) to administer JAG201, a gene replacement therapy, to both paediatric and adult patients in a Phase I clinical trial for autism. JAG201 targets a genetic form of …